Skip to Main Content

Paper Details

Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial.
Clin Cancer Res
85
2016
CD133, CD133+, CD133+ CIS population, CIS, CISs, Glioma, High, High-grade gliomas, NICD, Notch, Notch intracellular domain, Patient, Patients, RO4929097, VEGF, anaplastic astrocytoma, cancer, cancer-initiating cell, gamma-secretase, glioblastoma, mesenchymal genes, organotypic tumor explants cultures, patients, plasma, recurrent, temozolomide, tumor, tumor cells, tumor tissue, tumors
Author NameAffiliation
Thomas J KaleyMemorial Sloan Kettering Cancer Center
Timothy A ChanMemorial Sloan Kettering Cancer Center
Timothy A ChanMemorial Sloan Kettering Cancer Center
Katherine S PanageasMemorial Sloan Kettering Cancer Center
  • 1 - 4

Datasets

Release 1.2